First Tracks Biotherapeutics (HAM:B43) FCF Margin %: 0.00% (As of Dec. 2024)


HAM:B43 First Tracks Biotherapeutics Inc HAM:B43
20 GF Score
Price €32.00
! 3 Warning Signs
View Full Analysis

What is First Tracks Biotherapeutics FCF Margin %?

First Tracks Biotherapeutics HAM:B43 +29.29% 20 FCF Margin % is 0.00% as of Dec. 2024. GuruFocus rates HAM:B43 with a GF Score™ of 20/100. The stock has 3 warning signs investors should review. Among 950 Biotechnology companies, First Tracks Biotherapeutics ranks worse than 105263.05% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. First Tracks Biotherapeutics's Free Cash Flow for the six months ended in Dec. 2024 was €-120.49 Mil. First Tracks Biotherapeutics's Revenue for the six months ended in Dec. 2024 was €0.00 Mil. Therefore, First Tracks Biotherapeutics's FCF Margin % for the quarter that ended in Dec. 2024 was 0.00%.

As of today, First Tracks Biotherapeutics's current FCF Yield % is -9.98%.

The historical rank and industry rank for First Tracks Biotherapeutics's FCF Margin % or its related term are showing as below:


HAM:B43's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -84.535
* Ranked among companies with meaningful FCF Margin % only.

First Tracks Biotherapeutics FCF Margin % Related Terms

First Tracks Biotherapeutics FCF Margin % Historical Data

* Premium members only.

The historical data trend for First Tracks Biotherapeutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

First Tracks Biotherapeutics FCF Margin % Chart

First Tracks Biotherapeutics Annual Data
Trend Dec23 Dec24
FCF Margin %
0.00 0.00

First Tracks Biotherapeutics Semi-Annual Data
Dec23 Dec24
FCF Margin % 0.00 0.00

HAM:B43 vs ALT, RGNX, MDXG: FCF Margin % Comparison

For the Biotechnology subindustry, First Tracks Biotherapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

First Tracks Biotherapeutics FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, First Tracks Biotherapeutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where First Tracks Biotherapeutics's FCF Margin % falls into.


HAM:B43
20GF Score
First Tracks Biotherapeutics Inc HAM:B43
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

First Tracks Biotherapeutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

First Tracks Biotherapeutics's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-120.487/0
= %

First Tracks Biotherapeutics's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-120.487/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
First Tracks Biotherapeutics (HAM:B43) has a FCF Margin % of 0.00% as of Dec. 2024. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on First Tracks Biotherapeutics and its competitors. According to the industry distribution chart, First Tracks Biotherapeutics ranks #999999 out of 950 companies in the Biotechnology industry.
Is First Tracks Biotherapeutics' FCF Margin % too high?
First Tracks Biotherapeutics' current FCF Margin % is 0.00%. Based on the distribution chart, First Tracks Biotherapeutics ranks #999999 out of 950 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, First Tracks Biotherapeutics has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does First Tracks Biotherapeutics' FCF Margin % compare to ALT and RGNX?
According to the Biotechnology industry distribution chart, First Tracks Biotherapeutics ranks #999999 out of 950 companies for FCF Margin %. This places First Tracks Biotherapeutics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on First Tracks Biotherapeutics and its competitors. First Tracks Biotherapeutics's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is First Tracks Biotherapeutics stock overvalued right now?
First Tracks Biotherapeutics (HAM:B43) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. First Tracks Biotherapeutics' overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For First Tracks Biotherapeutics (HAM:B43), the current FCF Margin % is 0.00% as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

First Tracks Biotherapeutics Business Description

Other Exchanges TRAX:USA
Address 10770 Wateridge Circle, Suite 210, San Diego, CA, USA, 92121
First Tracks Biotherapeutics Inc is a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases. Its clinical-stage pipeline includes rosnilimab, a selective pathogenic T cell depleter, for which it completed a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA), ANB033, a CD122 antagonist, in a Phase 1b trial for celiac disease (CeD) and eosinophilic esophagitis (EoE), and ANB101, a BDCA2 modulator, in a Phase 1a trial. The company operates in one reportable segment focused on research and development activities to deliver immunology therapeutics for autoimmune and inflammatory diseases.
20GF Score

Get the complete analysis for HAM:B43

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€32.00
Price